Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R King

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology Clinics of North America|February 12, 2018
Ethnicity-Based Carrier ScreeningJennifer R King, Susan Klugman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Methods for integration of pharmacokinetic and phenotypic information in the treatment of infection with human immunodeficiency virusEdward P Acosta, Jennifer R King
Clinical Pharmacology in Drug Development|March 7, 2017
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs forSubstance AbuseJennifer R King, Rajeev M Menon
Clinical Pharmacokinetics|June 29, 2006
Tipranavir: a novel nonpeptidic protease inhibitor of HIVJennifer R King, Edward P Acosta
Clinical Pharmacokinetics|September 29, 2012
Pharmacokinetic optimization of antiretroviral therapy in pregnancyKajal Buckoreelall, Tim R Cressey, Jennifer R King
Current HIV/AIDS Reports|January 20, 2009
Pharmacologic aspects of new antiretroviral drugsMary C Long, Jennifer R King, Edward P Acosta
Current Infectious Disease Reports|October 24, 2008
Pharmacologic aspects of new antiretroviral drugsMary C Long, Jennifer R King, Edward P Acosta
Adolescent Health, Medicine and Therapeutics|March 7, 2014
Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokineticsKajal B Larson, Jennifer R King, Edward P Acosta
Clinical Pharmacokinetics|April 15, 2004
Pharmacokinetic enhancement of protease inhibitor therapyJennifer R King, Heather Wynn, Richard Brundage, et al.
ACS Chemical Neuroscience|January 12, 2017
Effect of Maternal ±Citalopram Exposure on P11 Expression and Neurogenesis in the Mouse Fetal BrainJennifer R King, Juan C Velasquez, Masaaki Torii, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology Clinics of North America|February 12, 2018
Ethnicity-Based Carrier ScreeningJennifer R King, Susan Klugman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Methods for integration of pharmacokinetic and phenotypic information in the treatment of infection with human immunodeficiency virusEdward P Acosta, Jennifer R King
Clinical Pharmacology in Drug Development|March 7, 2017
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs forSubstance AbuseJennifer R King, Rajeev M Menon
Clinical Pharmacokinetics|June 29, 2006
Tipranavir: a novel nonpeptidic protease inhibitor of HIVJennifer R King, Edward P Acosta
Clinical Pharmacokinetics|September 29, 2012
Pharmacokinetic optimization of antiretroviral therapy in pregnancyKajal Buckoreelall, Tim R Cressey, Jennifer R King
Current HIV/AIDS Reports|January 20, 2009
Pharmacologic aspects of new antiretroviral drugsMary C Long, Jennifer R King, Edward P Acosta
Current Infectious Disease Reports|October 24, 2008
Pharmacologic aspects of new antiretroviral drugsMary C Long, Jennifer R King, Edward P Acosta
Adolescent Health, Medicine and Therapeutics|March 7, 2014
Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokineticsKajal B Larson, Jennifer R King, Edward P Acosta
Clinical Pharmacokinetics|April 15, 2004
Pharmacokinetic enhancement of protease inhibitor therapyJennifer R King, Heather Wynn, Richard Brundage, et al.
ACS Chemical Neuroscience|January 12, 2017
Effect of Maternal ±Citalopram Exposure on P11 Expression and Neurogenesis in the Mouse Fetal BrainJennifer R King, Juan C Velasquez, Masaaki Torii, et al.
Pageof 5